While much of Valneva's focus these days is centered on its landmark vaccine for chikungunya virus, the French immunization specialist's catalog of older shots continues to serve up fresh governmen | ...

A RESIDENT has expressed their concern at the difficulty and confusion surrounding access to a potentially life-saving vaccine. Offering protection against the Japanese Encephalitis Virus (JEV), a ...

A study was conducted to assess the safety and tolerability of the tetravalent live-attenuated dengue vaccine Qdenga®, which received marketing approval in Germany in 2022. The study evaluated vaccine ...

In a report released on January 31, Justine Telliez from Kepler Capital maintained a Buy rating on Valneva (0OB3 – Research Report), with a ...

Kennedy is denying the facts – that vaccines are one of the most powerful interventions in history. That they have saved ...

At Nong Samor Sub-district Health Promoting Hospital, East Pattaya, parents brought their children, aged newborn to four ...

Nov. 3, 2023 — Researchers have pioneered a novel treatment for the most common autoimmune encephalitis. By reprogramming white blood cells to target and eliminate ... The Quail Could Be the ...

The battle to drastically reduce, if not totally eradicate, dengue cases must involve yearlong efforts. It cannot be a ...

Hundreds of people gathered Sunday at a Buddhist temple in downtown Tokyo, eagerly stretching their hands to catch the dried ...

Valneva (NASDAQ:VALN – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a report released on Friday,Benzinga reports. They currently have a $18.00 price target on the stock ...